Sign in to view content

Randomized Trial of PRP vs Intravitreal Ranibizumab Plus Deferred PRP for Proliferative Diabetic Retinopathy

Andrew N. Antoszyk, MD FASRS

Video
Published 2016

Related

Endolaserless Vitrectomy with Intravitreal Aflibercept
Dennis M. Marcus, MD
Updates from the Field
2017
Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2021
Randomized Trial of Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: 5-Year Outcomes
Jeffrey G. Gross, MD, FASRS
Updates from the Field
2018

Category: Diabetic Retinopathy

See more